Can volume indices of total, free, and complex prostate-specific antigen enhance the prediction of the pathologic stage of clinical T1C prostate cancer?

被引：0
|
作者：
Naya, Y
Fritsche, HA
Stamey, TA
Cheli, CD
Partin, AW
Sokoll, LL
Chan, DW
Brawer, MK
Taneja, SS
Lepor, H
Bartsch, G
Childs, S
Babaian, RJ
机构：
来源：
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1137
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [31] Utility of total prostate-specific antigen and free prostate-specific antigen index to detect prostate cancer in the asymptomatic patient
    Rivera-Sanchez, Roberto
    Parre-Mendez, Carlos
    Luisa Caballero-Juradoc, Maria
    Flores-Paz, Rocio
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2022, 56 (01): : 11 - 15
  • [32] Prediction of pathological stage in patients with clinical stage T1c prostate cancer: The new challenge
    Veltri, RW
    Miller, MC
    Mangold, LA
    O'Dowd, GJ
    Epstein, JI
    Partin, AW
    JOURNAL OF UROLOGY, 2002, 168 (01): : 100 - 104
  • [33] ANALYSIS OF T1C PROSTATE CANCERS TREATED AT VERY LOW PROSTATE-SPECIFIC ANTIGEN (PSA) LEVELS
    Stephenson, Andrew J.
    Jones, J. Stephen
    Hernandez, Adrian V.
    Ciezki, Jay P.
    Gong, Michael C.
    Klein, Eric A.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 801 - 801
  • [34] Complexed prostate-specific antigen, and complext prostate-specific antigen indices for early detection of prostate cancer in men with total prostate-specific antigen between 2.0 and 4.0 ng/ml
    Reissigl, A
    Remzi, M
    Wiunig, C
    Zlotta, A
    Ravery, V
    Hammerer, P
    Dobronski, P
    Kaisary, A
    Marberger, M
    Djavan, B
    JOURNAL OF UROLOGY, 2003, 169 (04): : 426 - 427
  • [35] Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis
    Lein, M
    Jung, K
    Elgeti, U
    Petras, T
    Stephan, C
    Brux, B
    Sinha, P
    Winkelmann, B
    Schnorr, D
    Loening, SA
    EUROPEAN UROLOGY, 2001, 39 (01) : 57 - 64
  • [36] Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination
    Finne, P
    Auvinen, A
    Aro, J
    Juusela, H
    Määttänen, L
    Rannikko, S
    Hakama, M
    Tammela, TLJ
    Stenman, UH
    EUROPEAN UROLOGY, 2002, 41 (06) : 619 - 626
  • [37] Prediction of significant cancer in men with stage T1c adenocarcinoma of the prostate
    Carter, HB
    Epstein, JI
    WORLD JOURNAL OF UROLOGY, 1997, 15 (06) : 359 - 363
  • [38] Free/total prostate-specific antigen ratio can prevent unnecessary prostate biopsies
    Trinkler, FB
    Schmid, DM
    Hauri, D
    Pei, P
    Maly, FE
    Sulser, T
    UROLOGY, 1998, 52 (03) : 479 - 486
  • [39] Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
    Choi, Hoon
    Park, Jae Young
    Shim, Ji Sung
    Kim, Jae Heon
    Bae, Jae Hyun
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2013, 17 (02) : 73 - 77
  • [40] Classifying prostate cancer patients based on total prostate-specific antigen and free prostate-specific antigen features by support vector machine
    Nguyen Thi Hong Nhung
    Vu Tran Minh Khuong
    Vu Quang Huy
    Pham The Bao
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (02) : 818 - 825
12345